Drug · DIN 02016087
PROHANCE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 30, 1998; first marketed December 31, 1993.
- Drug Identification Number (DIN)
- 02016087
- Company (DIN owner)
- Squibb Diagnostics, Division Of Bristol-Myers Squibb Canada Inc.Montreal, Quebec, Canada
- Schedule
- Ethical
- Dosage form
- Liquid
- Route
- Intravenous
- Therapeutic class (ATC)
- Gadoteridol V08CA04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GADOTERIDOL | 279.3 MG | ML |
Other DINs named PROHANCE
- DIN 02229056 · Marketed